Actinium Pharmaceuticals, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Actinium Pharmaceuticals, Inc. (ATNM) on November 9, 2021. The report details the outcomes of the Company's 2021 Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and equity plan amendments.
Material Changes and Corporate Actions
- Director Elections: Sandesh Seth and Jeffrey W. Chell were elected as Class II directors. Their terms will expire at the 2024 Annual Meeting of Stockholders.
- Equity Plan Amendment: Stockholders approved the Second Amendment to the 2019 Equity Incentive Plan. This amendment increases the number of shares available for issuance by 2,750,000, raising the total authorized shares under the plan to 5,833,333.
- Auditor Ratification: Stockholders ratified the appointment of Marcum LLP as the independent registered public accounting firm for the 2021 fiscal year.
Voting Results
A total of 12,755,273 shares were present or represented by proxy at the meeting. The voting results were as follows:
| Proposal | For | Against | Withheld/Abstained |
|---|---|---|---|
| Election of Sandesh Seth | 4,075,776 | 0 | 2,111,222 |
| Election of Jeffrey W. Chell | 5,144,927 | 0 | 1,042,071 |
| Amendment to 2019 Plan | 3,740,294 | 2,212,770 | 233,934 |
| Ratification of Auditor | 12,371,473 | 137,529 | 246,271 |
Note: There were 6,568,275 broker non-votes recorded for the director elections and the plan amendment.
Guidance, Outlook, and Risks
The filing does not provide management commentary on future guidance, outlook, risks, contingencies, or unusual items. It strictly reports on the completion of the annual meeting and the specific votes cast.
Investor Verification Checklist
- Verify the effective date of the Second Amendment to the 2019 Plan (stated as November 18, 2020, for the first amendment; the Second Amendment was approved at the meeting).
- Review the full text of the Second Amendment filed as Exhibit 10.1 for specific terms regarding the increased share pool.
- Confirm the terms of the newly elected directors (Sandesh Seth and Jeffrey W. Chell) expire in 2024.
- Check the 2021 Proxy Statement for detailed biographies of the directors and the rationale for the equity plan increase.